Related Experiment Video
Updated: Jul 5, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Patient-targeted education (ePRO-E) to increase ePRO intent within an Alliance clinical trial (A221805-SI1)
Ellen M Lavoie Smith1, Youmin Cho2, Shauna Hillman3
1Department of Acute, Chronic and Continuing Care, University of Alabama at Birmingham School of Nursing, Birmingham, AL, USA.
A new educational resource improved patient-reported outcome (ePRO) intent in cancer trials, but did not increase high-quality data submission. Further strategies are needed to boost ePRO data quality.
Area of Science:
- Oncology
- Clinical Trials
- Health Informatics
Background:
- The National Cancer Institute National Clinical Trials Network (NCTN) adopted the Patient Cloud ePRO app for electronic patient-reported outcome (ePRO) data collection.
- Low utilization of the ePRO app within the NCTN has been observed, necessitating strategies to improve adoption and data quality.
Purpose of the Study:
- To evaluate the effectiveness of a patient-targeted ePRO educational resource (ePRO-E) in increasing ePRO intent and improving data quality within an NCTN study.
- To assess the impact of technology attitudes on ePRO selection.
Main Methods:
- A prospective study compared an intervention group exposed to the ePRO-E (written materials and video) with a historical control group.
- ePRO intent and data quality (≥80% survey submission) were primary outcomes, with covariates including technology attitudes, demographics, and comorbidity.
- A total of 69 participants were included in the comparison.
Main Results:
- The intervention group showed significantly higher ePRO intent (78.8%) compared to the historical control group (47.1%).
- Patients with higher technology attitudes were more likely to choose ePRO surveys.
- Despite increased intent, the ePRO group had a significantly lower data submission rate (30.6%) compared to the paper survey group (57.9%).
Conclusions:
- The ePRO-E intervention successfully increased patient intent to use electronic patient-reported outcomes.
- Positive technology attitudes are associated with higher ePRO adoption.
- Additional strategies are required to enhance the quality and completeness of ePRO data submission in clinical trials.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Prodrugs
Prodrugs help overcome...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

